- Home
- SCOR vs LSB Comparison
SCOR vs LSB Comparison
Compare SCOR & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- LSB
- Stock Information
- Founded
- SCOR 1999
- LSB 2002
- Country
- SCOR United States
- LSB China
- Employees
- SCOR N/A
- LSB N/A
- Industry
- SCOR Business Services
- LSB
- Sector
- SCOR Consumer Discretionary
- LSB
- Exchange
- SCOR Nasdaq
- LSB NYSE
- Market Cap
- SCOR 23.9M
- LSB 22.3M
- IPO Year
- SCOR 2007
- LSB N/A
- Fundamental
- Price
- SCOR $5.52
- LSB $1.05
- Analyst Decision
- SCOR Buy
- LSB
- Analyst Count
- SCOR 2
- LSB 0
- Target Price
- SCOR $10.75
- LSB N/A
- AVG Volume (30 Days)
- SCOR 22.7K
- LSB 824.4K
- Earning Date
- SCOR 08-05-2025
- LSB 07-22-2025
- Dividend Yield
- SCOR N/A
- LSB N/A
- EPS Growth
- SCOR N/A
- LSB N/A
- EPS
- SCOR N/A
- LSB N/A
- Revenue
- SCOR $354,961,000.00
- LSB $79,415,311.00
- Revenue This Year
- SCOR $3.36
- LSB $39.33
- Revenue Next Year
- SCOR $2.72
- LSB $75.61
- P/E Ratio
- SCOR N/A
- LSB N/A
- Revenue Growth
- SCOR N/A
- LSB N/A
- 52 Week Low
- SCOR $4.39
- LSB $0.36
- 52 Week High
- SCOR $15.31
- LSB $6.82
- Technical
- Relative Strength Index (RSI)
- SCOR 59.22
- LSB 50.39
- Support Level
- SCOR $4.39
- LSB $0.93
- Resistance Level
- SCOR $5.93
- LSB $1.48
- Average True Range (ATR)
- SCOR 0.32
- LSB 0.11
- MACD
- SCOR 0.08
- LSB 0.03
- Stochastic Oscillator
- SCOR 63.06
- LSB 30.51
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.